ConvaTec

UK medical products and technologies company

London SE ISIN GB00BD3VFW73 LEI 213800LS272L4FIDOH92
Follow ConvaTec Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2025 USD · IFRS
Revenue, last year $2.4B +6.5% vs prior year
Net income $175M −8.1% vs prior year
EPS, diluted $0.09 −7.5% vs prior year
Operating cash flow $470M +18.6% vs prior year
Revenue by fiscal year
$2B
$2.1B
$2.1B
$2.3B
$2.4B
FY21 FY22 FY23 FY24 FY25

Source: ESEF annual reports · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income5 fiscal years
  • Revenue
  • Net income
$0$1B$2B$3BFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$2.4B$175M
FY24$2.3B$190.5M
FY23$2.1B$130.3M
FY22$2.1B$62.9M
FY21$2B$117.6M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2556.2%13%7.2%
FY2456.1%14.2%8.3%
FY2356%12.3%6.1%
FY2253.3%10%3%
FY2155.1%10%5.8%
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$200M$400M$600MFY21FY22FY23FY24FY25
Show the numbers
YearDividendsBuybacks
FY25$140M$326M
FY24$130.2M$10.9M
FY23$110.7M-
FY22$88.1M-
FY21$85.8M-